RxDoctor Payments Data

Bishal Malla

Family · Frederick, MDNPI 1801485768

Payments from drug & device makers

$1,189in general payments, 2019–2025

Across 65 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$416
  • Scilex Pharmaceuticals Inc.$198
  • Boston Scientific$103
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$96
  • Electronic Waveform Lab, Inc.$85
  • C. R. Bard, Inc. & Subsidiaries$38
  • plus $253 from 11 others

What the payments were for

  • Speaking & faculty fees$383%
  • Food & beverage$1,15197%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,189 in reported general payments places this provider in the 70th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland

Medicare billing

Part B allowed, 2024
$22,515
Medicare patients
107
Services billed
292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl254$136,268
Xtampza ErOxycodone Myristate81$31,875
Oxycodone Hcl1,184$23,857
Hysingla ErHydrocodone Bitartrate35$22,392
NucyntaTapentadol Hcl15$20,756
Morphine Sulfate ErMorphine Sulfate535$17,411
MovantikNaloxegol Oxalate31$15,751
Fentanyl106$10,706
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen324$9,491
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl61$9,029
ZtlidoLidocaine20$8,589
Buprenorphine22$6,747
Lidocaine45$6,397
Hydromorphone ErHydromorphone Hcl15$5,017
Gabapentin393$4,614

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta$416$52,63196 claims
Scilex Pharmaceuticals Inc.Ztlido$198$8,58920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,843 family providers in Maryland.

Other family in Frederick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →